LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 18.03
(-1.04%)
CNY 18.03
(-1.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 22.35 Billion | 20.17 Billion | 15.69 Billion | 13.96 Billion | 11.66 Billion | 9.47 Billion |
| Cost of Revenue | 16.58 Billion | 13.74 Billion | 10.65 Billion | 9.48 Billion | 7.74 Billion | 6.13 Billion |
| Gross Profit | 5.77 Billion | 6.43 Billion | 5.04 Billion | 4.47 Billion | 3.91 Billion | 3.33 Billion |
| Operating Expenses | 5.88 Billion | 5 Billion | 3.92 Billion | 3.41 Billion | 3.06 Billion | 2.65 Billion |
| Selling, General and Administrative Expenses | 5.76 Billion | 4.13 Billion | 3.46 Billion | 3 Billion | 2.67 Billion | 2.3 Billion |
| Research and Development Expenses | 2.51 Million | 2.23 Million | - | 150 Thousand | 1.35 Million | 6.23 Million |
| Other Expenses | 116.77 Million | 870.74 Million | 464.64 Million | 412 Million | 390.59 Million | 7.42 Million |
| Cost and Expenses | 21.03 Billion | 18.75 Billion | 14.57 Billion | 12.9 Billion | 10.81 Billion | 8.78 Billion |
| Operating Income | 1.39 Billion | 1.2 Billion | 956.46 Million | 959.51 Million | 765.06 Million | 628.85 Million |
| Interest Expense | 185.6 Million | 232.13 Million | 192.13 Million | 58.49 Million | 57.94 Million | 47.08 Million |
| Income Tax Expense | 284.27 Million | 231.37 Million | 175.25 Million | 192.37 Million | 155.4 Million | 132.27 Million |
| Earnings before Tax | 1.4 Billion | 1.2 Billion | 961.98 Million | 956.86 Million | 770.38 Million | 636.28 Million |
| Net Income | 929.02 Million | 784.96 Million | 669.23 Million | 621.09 Million | 508.71 Million | 435.03 Million |
| Earnings Per Share Basic | 1.22 | 1.36 | 1.26 | 1.18 | 0.98 | 0.84 |
| Earnings Per Share Diluted | 1.22 | 1.36 | 1.26 | 1.17 | 0.97 | 0.84 |
| Weighted Average Shares Outstanding | 759.57 Million | 577.17 Million | 530.49 Million | 524.29 Million | 518.6 Million | 517.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 759.57 Million | 577.17 Million | 530.49 Million | 531.19 Million | 524.86 Million | 517.49 Million |
| Gross Margin | 0.26 | 0.32 | 0.32 | 0.32 | 0.34 | 0.35 |
| EBIT Margin | 0.14 | 0.13 | 0.14 | 0.08 | 0.08 | 0.08 |
| Profit Margin | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 |
| EBITDA | 3.06 Billion | 2.77 Billion | 2.37 Billion | 1.27 Billion | 1.04 Billion | 921.57 Million |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 5.29 Billion | 5.38 Billion | 5.52 Billion | 22.35 Billion | 6.36 Billion | 5.23 Billion |
| Cost of Revenue | 3.54 Billion | 3.97 Billion | 3.58 Billion | 16.58 Billion | 4.68 Billion | 3.55 Billion |
| Gross Profit | 1.74 Billion | 1.4 Billion | 1.93 Billion | 5.77 Billion | 1.67 Billion | 1.67 Billion |
| Operating Expenses | 1.48 Billion | 1.1 Billion | 1.44 Billion | 4.33 Billion | 1.32 Billion | 1.37 Billion |
| Selling, General and Administrative Expenses | 3.28 Billion | 1.09 Billion | 1.44 Billion | - | 1.31 Billion | 1.73 Billion |
| Research and Development Expenses | 219.02 Thousand | 223.83 Thousand | 196.06 Thousand | - | 1.82 Million | 229.2 Thousand |
| Other Expenses | -1.8 Billion | -3.57 Million | 5600.00 | -21.88 Million | -12.96 Million | 1.65 Million |
| Cost and Expenses | 5.03 Billion | 5.07 Billion | 5.03 Billion | 20.92 Billion | 6.01 Billion | 4.93 Billion |
| Operating Income | 213.54 Million | 302.9 Million | 488.19 Million | 1.43 Billion | 348.57 Million | 307.83 Million |
| Interest Expense | 46.88 Million | 47.65 Million | 42.47 Million | 185.6 Million | - | - |
| Income Tax Expense | 54.27 Million | 52.8 Million | 94.34 Million | 284.27 Million | 68.53 Million | 67.71 Million |
| Earnings before Tax | 210.13 Million | 274.38 Million | 460.63 Million | 1.4 Billion | 337.96 Million | 309.49 Million |
| Net Income | 127.44 Million | 181.44 Million | 321.25 Million | 929.02 Million | 212.46 Million | 203.31 Million |
| Earnings Per Share Basic | 0.17 | 0.24 | 0.55 | - | 0.36 | 0.34 |
| Earnings Per Share Diluted | 0.17 | 0.24 | 0.55 | - | 0.36 | 0.34 |
| Weighted Average Shares Outstanding | 757.91 Million | 757.91 Million | 582.34 Million | 584.29 Million | 587.46 Million | 595.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 757.91 Million | 757.91 Million | 582.34 Million | 584.29 Million | 587.46 Million | 595.56 Million |
| Gross Margin | 0.33 | 0.26 | 0.35 | 0.26 | 0.26 | 0.32 |
| EBIT Margin | 0.05 | 0.13 | 0.09 | - | 0.12 | 0.05 |
| Profit Margin | 0.02 | 0.03 | 0.06 | 0.04 | 0.03 | 0.04 |
| EBITDA | 256.64 Million | 700.16 Million | 501.21 Million | - | 736.36 Million | 243.88 Million |
| Earnings Before Tax Margin | 0.04 | 0.06 | 0.09 | 0.06 | 0.05 | 0.06 |
002802
ELMN
CNTR
600792
ALSN
014620